EUVIMEDEUVIMED entdecken
Crossref

Lipiodol-Mediated Dose Enhancement in Radiation Therapy: A Phantom and In Vitro Study in Hepatocellular Carcinoma

Kentaro Yamada, Kenkichi Michimoto, Arianna Anoushiravani, Takeshi Suzuki, Todd Graham, Austin Bunker, Andrew Bertinetti, Nima Nabavizadeh, Rachel T Huynh, Joshua M Walker, Khashayar Farsad

CardioVascular and Interventional Radiology · 2026

DOI: 10.1007/s00270-026-04351-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CardioVascular and Interventional Radiology, 2026. Verfasst von Kentaro Yamada und 10 weiteren Autor:innen. Beteiligte Einrichtung: Dotter Department of Interventional Radiology, Oregon Health and Science University, 3181 Sam Jackson Park Road, Portland, OR, 97239, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Ethiodized Oil. Die Arbeit nennt 22 Literaturangaben. Gefördert von: Guerbet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To assess Lipiodol-mediated photon dose perturbation and biological effects using complementary kilovoltage and megavoltage irradiation geometries relevant to hepatocellular carcinoma. MATERIALS AND METHODS: Phantom dosimetry used containers filled with lipiodol-oil mixtures (0-100%) embedded in a water phantom with radiochromic film to quantify concentration-dependent enhancement under 6-MV beam. HepG2 human hepatoma cells were irradiated at 0-6 Gy using 160-kVp (photoelectric effect dominant) with lipiodol or water placed beneath the cell monolayer to isolate backscatter; γH2AX foci indicating DNA damage were quantified shortly after irradiation. For megavoltage testing, a 6-MV (Compton scattering dominant) Lipiodol-rich "sandwich" geometry (Lipiodol above and below the cell monolayer) was used; apoptosis was quantified at 96 h using NucView/NucSpot (apoptotic fraction), and results are reported descriptively. RESULTS: Film dosimetry demonstrated increasing enhancement with Lipiodol concentration, spatially localized to the Lipiodol region, with a maximum localized increase of 57.1% at 100% Lipiodol versus water. In the 160-kVp backscatter model, higher γH2AX foci were observed at 4 and 6 Gy in Lipiodol versus control. In the 6-MV sandwich model, cell-plane film confirmed an 11.5% higher delivered dose at 2 Gy with Lipiodol and apoptotic fraction was 1.36-5.79-fold higher across 2-6 Gy compared to the control. CONCLUSION: Lipiodol measurably intensified local photon dose and was associated with greater DNA damage and apoptosis in phantom and HepG2 cell models. These findings provide mechanistic support for combining radiotherapy with Lipiodol-based transarterial treatments and highlight the need for further in vivo validation and clinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsEthiodized OilHumansPhantoms, ImagingApoptosisHep G2 CellsRadiotherapy DosageContrast MediaDNA Damage

Stichwörter der Autor:innen

Dose enhancementEthiodized oilHepatocellular carcinomaLipiodolRadiation therapyTransarterial chemoembolization

Substanzen

Ethiodized OilContrast Media

Autor:innen und Institutionen

  • Dotter Department of Interventional Radiology, Oregon Health and Science University, 3181 Sam Jackson Park Road, Portland, OR, 97239, USA.
  • Department of Radiation Oncology, Northwestern Medicine Kishwaukee Cancer Center, 10 Health Services Dr, DeKalb, IL, 60115, USA.
  • Department of Radiation Medicine, Oregon Health & Science University, 3181 Sam Jackson Park Road, Portland, OR, 97239, USA.
  • Department of Cell, Developmental and Cancer Biology, School of Medicine, Oregon Health & Science University, 3181 Sam Jackson Park Road, PortlandPortland, OR, 97239, USA.
  • Dotter Department of Interventional Radiology, Oregon Health and Science University, 3181 Sam Jackson Park Road, Portland, OR, 97239, USA. farsad@ohsu.edu.

Förderung

  • Guerbet

Zitieren

APA

Yamada, K., Michimoto, K., Anoushiravani, A., Suzuki, T., Graham, T., Bunker, A., Bertinetti, A., Nabavizadeh, N., Huynh, R. T., Walker, J. M., & Farsad, K. (2026). Lipiodol-Mediated Dose Enhancement in Radiation Therapy: A Phantom and In Vitro Study in Hepatocellular Carcinoma. CardioVascular and Interventional Radiology. https://doi.org/10.1007/s00270-026-04351-4

Vancouver

Yamada K, Michimoto K, Anoushiravani A, Suzuki T, Graham T, Bunker A, et al. Lipiodol-Mediated Dose Enhancement in Radiation Therapy: A Phantom and In Vitro Study in Hepatocellular Carcinoma. CardioVascular and Interventional Radiology. 2026. doi:10.1007/s00270-026-04351-4

BibTeX
@article{Yamada2026,
  author = {Yamada, Kentaro and Michimoto, Kenkichi and Anoushiravani, Arianna and Suzuki, Takeshi and Graham, Todd and Bunker, Austin and Bertinetti, Andrew and Nabavizadeh, Nima and Huynh, Rachel T and Walker, Joshua M and Farsad, Khashayar},
  title = {Lipiodol-Mediated Dose Enhancement in Radiation Therapy: A Phantom and In Vitro Study in Hepatocellular Carcinoma},
  journal = {CardioVascular and Interventional Radiology},
  year = {2026},
  doi = {10.1007/s00270-026-04351-4}
}
Kostenlos starten →